BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 30, 2015
View Archived Issues
RNA vaccine iHIVARNA-01 enters phase I trial in patients with HIV-1 infection
Read More
AbbVie presents key events from second quarter 2015
Read More
Heptares and Regeneron enter StaR protein collaboration
Read More
DNDi and Takeda collaborate on aminopyrazole series for visceral leishmaniasis
Read More
Cross-talk between Ret and Parkin has a key role in dopaminergic neuron survival
Read More
Catabasis Pharmaceuticals sponsors research into SREBP pathway involvement in lipid disorders
Read More
Boehringer Ingelheim signs license agreement with Hanmi for HM-61713
Read More
Oncolys BioPharma and Kagoshima University to jointly search for novel anti-HBV agents
Read More
Merck & Co. to acquire CEACAM-1 targeting immunotherapy developer cCAM Biotherapeutics
Read More
Bristol-Myers Squibb introduces ROR-gamma modulators
Read More
Pfizer reflects on key milestones of second quarter 2015
Read More
Qu Biologics begins phase II trial of QBECO SSI for ulcerative colitis
Read More
Inovio Pharmaceuticals begins trial of INO-5150 for prostate cancer
Read More
Patient-derived antibody is active against Middle East Respiratory Syndrome
Read More
A*STAR discloses MNK inhibitors
Read More
Novartis introduces PTP-2C inhibitors
Read More
Aurigene presents BET protein inhibitors
Read More
CIMA patents antifibrinolytics
Read More
Arena Pharmaceuticals begins phase II trial of APD-334
Read More
FDA clears IND for RXDX-107
Read More
Osteoprotegerin levels indicative of aortic valvular stenosis
Read More
New start-up Mereo BioPharma acquires programs from Novartis
Read More
Kyowa Hakko Kirin and BMS to study combination of mogamulizumab and nivolumab
Read More
Navidea receives NIH grants to study Manocept in atherosclerosis and rheumatoid arthritis
Read More
Astellas reports topline data from ACTIVE study of isavuconazole
Read More
FDA clears KaloBios' IND for KB-003 for chronic myelomonocytic leukemia
Read More
FDA accepts NDA for ZS-9 in hyperkalemia
Read More
